Skip to main content
Dong-E-E-Jiao Co., Ltd. logo

Dong-E-E-Jiao Co., Ltd. — Investor Relations & Filings

Ticker · 000423 ISIN · CNE0000006Y9 LEI · 655600E60FK5WI9EWB37 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,500 across all filing types
Latest filing 2026-05-15 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 000423

About Dong-E-E-Jiao Co., Ltd.

https://www.dongeejiao.com

Dong-E-E-Jiao Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine, with a primary focus on E-Jiao (donkey-hide gelatin) and its derivative products. The company’s core portfolio includes E-Jiao blocks, Fufang Ejiao Jiang, and various health supplements designed for blood nourishment and overall wellness. Recognized for its commitment to quality and heritage, the firm integrates a complete industrial chain encompassing donkey breeding, processing technology, and pharmaceutical manufacturing. It leverages modern scientific research to standardize traditional production methods, ensuring product efficacy and safety. Serving a broad consumer base seeking natural health solutions, the company maintains a dominant position in the tonic market through its focus on brand integrity and the preservation of national intangible cultural heritage.

Recent filings

Filing Released Lang Actions
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is titled “2025年年度股东会决议公告” and provides detailed vote tallies for each proposal at the annual general meeting, including attendance, voting methods, and results. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA), which covers official shareholder vote outcomes at an AGM.
2026-05-15 Chinese
北京金诚同达律师事务所关于东阿阿胶股份有限公司2025年年度股东会的法律意见书
AGM Information Classification · 85% confidence The document is a lawyer’s legal opinion letter (“法律意见书”) issued by a law firm regarding the convening, procedures, attendee qualifications, proposal review, and vote results of the company’s 2025 Annual General Meeting of shareholders. It does not itself announce share issues, financing, management changes, nor is it a proxy solicitation or interim report. It serves as a material provided in connection with the AGM. Under the filing definitions, this fits “AGM Information (Code: AGM-R)”.
2026-05-15 Chinese
关于以集中竞价交易方式回购公司股份的进展公告
Regulatory Filings
2026-05-07 Chinese
2025年年度审计报告
Regulatory Filings
2026-03-19 Chinese
2025年年度报告
Regulatory Filings
2026-03-19 Chinese
独立董事2025年度述职报告(程翔林)
Regulatory Filings
2026-03-19 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.